BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

941 related articles for article (PubMed ID: 26956419)

  • 1. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.
    Gu H; Mickler EA; Cummings OW; Sandusky GE; Weber DJ; Gracon A; Woodruff T; Wilkes DS; Vittal R
    FASEB J; 2014 Oct; 28(10):4223-34. PubMed ID: 24958208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis.
    Cipolla E; Fisher AJ; Gu H; Mickler EA; Agarwal M; Wilke CA; Kim KK; Moore BB; Vittal R
    FASEB J; 2017 Dec; 31(12):5543-5556. PubMed ID: 28821630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
    Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
    Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
    Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
    J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.
    Strainic MG; Shevach EM; An F; Lin F; Medof ME
    Nat Immunol; 2013 Feb; 14(2):162-71. PubMed ID: 23263555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.
    Liu L; Zhang Y; Duan X; Peng Q; Liu Q; Zhou Y; Quan S; Xing G
    J Clin Immunol; 2014 Feb; 34(2):224-32. PubMed ID: 24327134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
    Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
    J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anaphylatoxin C3a, C5a on the tubular epithelial-myofibroblast transdifferentiation in vitro.
    Liu F; Gou R; Huang J; Fu P; Chen F; Fan WX; Huang YQ; Zang L; Wu M; Qiu HY; Wei DP
    Chin Med J (Engl); 2011 Dec; 124(23):4039-45. PubMed ID: 22340339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement gene expression is regulated by pro-inflammatory cytokines and the anaphylatoxin C3a in human tenocytes.
    Busch C; Girke G; Kohl B; Stoll C; Lemke M; Krasnici S; Ertel W; Silawal S; John T; Schulze-Tanzil G
    Mol Immunol; 2013 Apr; 53(4):363-73. PubMed ID: 23070120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the anaphylatoxin receptors, complement anaphylatoxin 3a receptor and complement anaphylatoxin 5a receptor, in the nasal mucosa of patients with mild and severe persistent allergic rhinitis.
    Jun SW; Kim TH; Lee HM; Lee SH; Kim WJ; Park SJ; Kim YS; Lee SH
    J Allergy Clin Immunol; 2008 Jul; 122(1):119-25. PubMed ID: 18538384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
    Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
    Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.
    Cravedi P; Leventhal J; Lakhani P; Ward SC; Donovan MJ; Heeger PS
    Am J Transplant; 2013 Oct; 13(10):2530-9. PubMed ID: 24033923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.
    Kwan WH; van der Touw W; Paz-Artal E; Li MO; Heeger PS
    J Exp Med; 2013 Feb; 210(2):257-68. PubMed ID: 23382542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
    Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
    J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Mechanisms Underlying TGF-β-mediated Complement Activation in Lung Fibrosis.
    Fisher AJ; Cipolla E; Varre A; Gu H; Mickler EA; Vittal R
    Cell Mol Med Open Access; 2017; 3(3):. PubMed ID: 29377033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
    Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
    J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-Regulation of C3aR/C5aR Inhibits Cell Proliferation and EMT in Hepatocellular Carcinoma.
    Chen B; Zhou W; Tang C; Wang G; Yuan P; Zhang Y; Bhushan SC; Ma J; Leng J
    Technol Cancer Res Treat; 2020; 19():1533033820970668. PubMed ID: 33176600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.
    Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A
    J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.